Related Experiment Video
Updated: Jan 1, 2026
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with
Sibo Tian1, Jeffrey M Switchenko2, Teng Fei2
1Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Background:
We compared overall survival (OS) between radiation therapy (RT) and chemoradiotherapy (CRT) in patients with anaplastic thyroid carcinoma (ATC) using a large database.
Methods:
The National Cancer Data Base was queried for ATC patients diagnosed between 2004 and 2013 who received RT or CRT. Groups were balanced by propensity score matching (PSM) on nine relevant variables. OS was also examined in five paired subgroups given known patient heterogeneity.
Results:
Of 858 total patients, 575 received CRT and 283 received RT. CRT was associated with decreased risk of death (hazard ratio [HR] 0.66, P < .001), 1-year OS 25.5% vs 14.3%. A survival advantage to CRT was seen using PSM cohorts (HR 0.75, P = .006). Those receiving definitive surgery saw the greatest benefit to CRT over RT (HR 0.65, P = .009), 1-year OS 39.6% vs 20.4%.
Conclusions:
CRT is associated with decreased risk of death in ATC; the magnitude of CRT vs RT benefit varied by subgroup.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
01:21Cancer Survival Analysis
01:24Kaplan-Meier Approach
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...